Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
50
Number of overlapping holdings
22.4%
% of IBB's 260 holdings also in CNCR
78.1%
% of CNCR's 64 holdings also in IBB
Overlap by Weight
Sector Drift (IBB minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
BIONTECH SE SPONSORED ADR | 2.0% | 1.8% | 1.8% |
 |
REGENERON PHARMACEUTICALS | 7.2% | 1.5% | 1.5% |
|
EXELIXIS INC | 1.2% | 1.8% | 1.2% |
 |
GENMAB A/S SPONSORED ADR | 1.1% | 1.7% | 1.1% |
|
REVOLUTION MEDICINES, INC. | 0.7% | 1.7% | 0.7% |
Position Highlights (Non-Overlapping Exposures)
IBB Overweight Relative to CNCR
|
VERTEX PHARMACEUTICALS INC | 9.6% |
|
GILEAD SCIENCES INC | 8.6% |
|
AMGEN INC | 8.4% |
|
REGENERON PHARMACEUTICALS | 5.8% |
|
ALNYLAM PHARMACEUTICALS INC | 3.5% |
 |
ARGENX SE ADR | 3.1% |
|
IQVIA HOLDINGS INC | 3.1% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.5% |
|
WATERS CORP | 2.3% |
|
NATERA INC | 2.3% |
IBB Underweight Relative to CNCR
|
FATE THERAPEUTICS INC | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
SUMMIT THERAPEUTICS INC | -1.9% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -1.8% |
|
2SEVENTY BIO, INC. | -1.8% |
|
Y-MABS THERAPEUTICS, INC. | -1.8% |
|
ARVINAS, INC. | -1.7% |
|
ZYMEWORKS INC. | -1.7% |
|
NUVATION BIO INC CLASS A | -1.6% |
 |
HUTCHISON CHINA MEDITECH LIMITED SPO | -1.6% |